Japan Retail Pharmacy Market By Type of Pharmacy (Chain Pharmacies, Independent Pharmacies, Hospital Pharmacies, Mail Order Pharmacies, Online Pharmacies); By Type of Prescription (Prescription Drugs (Rx), Over-the-Counter (OTC) Drugs); By Service Offered (Medication Dispensing, Health Screenings, Vaccination Services, Consultation and Counseling, Chronic Disease Management); By Product Type (Generic Drugs, Branded Drugs); By Application (Oncology, Diabetes, Neurology, Others); By Customer (Paediatric, Adults, Geriatric); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Price: $2699
Published: | Report ID: 91221 | Report Format : Excel, PDF
The Japan Retail Pharmacy Market is projected to grow from USD 52,569.90 million in 2024 to an estimated USD 73,311.06 million by 2032, with a compound annual growth rate (CAGR) of 4.24% from 2025 to 2032. This growth is driven by the increasing demand for healthcare services, particularly among the aging population, and the expansion of retail pharmacy networks across the country.
Key drivers of market growth include the aging demographic, which leads to a higher prevalence of chronic diseases and a greater need for pharmaceutical care. Additionally, the expansion of retail pharmacy chains and the increasing availability of OTC products contribute to market growth. Technological advancements, such as pharmacy automation and digital health services, are also enhancing operational efficiency and customer experience.
Geographically, the Kanto region, encompassing Tokyo, is the largest market for retail pharmacies, driven by its dense population and high healthcare demand. Other regions, including Kansai and Chubu, are also experiencing growth due to expanding pharmacy networks and increasing consumer awareness. Major players in the market include Tsuruha Holdings, Welcia Holdings, and Matsumoto Kiyoshi Holdings, which dominate the retail pharmacy landscape with extensive store networks and a wide range of pharmaceutical products.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
The Japan Retail Pharmacy Market is projected to grow from USD 52,569.90 million in 2024 to USD 73,311.06 million by 2032, with a CAGR of 4.24% from 2025 to 2032.
The Global Retail Pharmacy Market is expected to grow from USD 14,45,920.00 million in 2024 to USD 19,65,958.05 million by 2032, at a CAGR of 3.92% from 2025 to 2032.
Key growth drivers include the aging population, increasing chronic disease prevalence, and the expansion of retail pharmacy networks across Japan.
The adoption of pharmacy automation, digital health services, and e-prescriptions are enhancing operational efficiency and customer experience in retail pharmacies.
The market faces challenges from regulatory hurdles and price pressure on pharmaceutical products, which may limit profit margins for pharmacy operators.
The Kanto region, including Tokyo, holds the largest market share due to its dense population and significant healthcare demand.
Kansai and Chubu regions are also witnessing growth, driven by expanding pharmacy networks and rising consumer awareness of healthcare options.
Major players such as Tsuruha Holdings, Welcia Holdings, and Matsumoto Kiyoshi Holdings dominate the market with extensive store networks and diverse product portfolios.
Report Scope
This report segments the Japan Retail Pharmacy Market as follows:
Market Drivers
Aging Population and Rising Prevalence of Chronic Diseases
Japan’s rapidly aging population significantly influences the growth trajectory of its retail pharmacy market. As of recent demographic estimates, over 29% of Japan’s total population is aged 65 years and older—a trend that is projected to intensify over the coming decades. This demographic shift has resulted in an increased prevalence of chronic diseases, including hypertension, diabetes, cardiovascular conditions, arthritis, and neurological disorders such as Alzheimer’s disease. Consequently, there is a rising demand for long-term prescription medications, continuous health monitoring, and preventive healthcare measures, all of which drive traffic to retail pharmacies. For instance, many pharmacies have introduced home visit pharmaceutical services, a government-supported initiative that aims to provide pharmaceutical support for elderly patients who have difficulty visiting healthcare institutions. This demographic-driven expansion of services strengthens the retail pharmacy ecosystem and enhances customer engagement while promoting medication adherence.
Expansion of OTC Drug Use and Consumer Health Awareness
The growing consumer inclination towards self-medication and preventive healthcare has accelerated the demand for over-the-counter (OTC) pharmaceuticals in Japan. Japanese consumers have increasingly taken a proactive approach to health management, seeking solutions for minor ailments such as allergies, digestive issues, cold and flu symptoms, and skin conditions without visiting a doctor. This behavioral shift has boosted OTC drug sales and expanded the product portfolio of retail pharmacies, making them integral points of primary healthcare access. For instance, the Japanese government has approved more “switch OTC” products—prescription drugs reclassified as OTC—which further expands the range of self-medication options available in retail outlets. Retail pharmacies in Japan are capitalizing on this trend by diversifying their offerings and enhancing in-store experiences through product consultations and tailored health solutions.
Digital Transformation and Integration of Pharmacy Automation
Digitalization and technological innovation represent crucial growth drivers for Japan’s retail pharmacy sector. Pharmacies are increasingly adopting pharmacy automation systems, such as automated dispensing machines, electronic prescription systems (e-prescriptions), and inventory management platforms. These technologies enhance operational efficiency, reduce medication errors, and improve prescription filling speed, thereby boosting customer satisfaction and workflow efficiency. Furthermore, the integration of electronic health records (EHRs) with pharmacy systems enables pharmacists to deliver more personalized and data-driven healthcare. Through EHR access, pharmacists can assess a patient’s medication history, identify drug interactions, and collaborate more effectively with physicians. In response to the COVID-19 pandemic and the broader push toward contactless services, many pharmacies also began offering telepharmacy services and digital consultations. These advancements not only align with Japan’s broader healthcare digitization efforts but also appeal to younger, tech-savvy consumers seeking convenience and rapid service delivery. In parallel, mobile applications and loyalty programs linked with pharmacy chains are being leveraged to drive engagement, allow for e-commerce purchases, and facilitate prescription refills or reminders. These innovations are transforming the traditional retail pharmacy model into a more responsive, omnichannel healthcare experience that addresses the evolving needs of modern consumers.
Policy Reforms and Government Support for Community Pharmacy Development
Japan’s government has implemented a range of policy reforms aimed at reinforcing the role of pharmacies within the national healthcare system. One of the cornerstone strategies is the promotion of “Health Support Pharmacies” (HSPs), which are accredited retail pharmacies that provide community-based services beyond conventional drug dispensing. HSPs offer services such as health promotion education, nutritional guidance, disease prevention consultations, and coordination with local healthcare providers to support patient-centered care. Additionally, the Ministry of Health, Labour and Welfare (MHLW) is actively encouraging the development of “family pharmacies” or “pharmacies of choice” that maintain long-term relationships with patients. These pharmacies are incentivized to keep comprehensive medication records and offer follow-up services, which not only contribute to improved therapeutic outcomes but also help reduce national healthcare expenditures by preventing duplicate prescriptions and adverse drug events. Pharmacy reimbursement models are also being revised to reward pharmaceutical care services rather than mere product sales. This shift recognizes the evolving role of pharmacists as healthcare providers who contribute to primary care and chronic disease management. By aligning financial incentives with healthcare goals, the Japanese government fosters a sustainable and community-integrated retail pharmacy model. Together, these regulatory measures and initiatives underscore the government’s commitment to fortifying Japan’s retail pharmacy infrastructure and enhancing its capacity to meet public health needs. They also create a favorable environment for private sector investment and innovation in pharmacy operations and services.
Market Trends
Rise of Omnichannel Retail and E-Pharmacy Integration
Japan’s retail pharmacy market is undergoing a significant transformation with the rapid integration of omnichannel strategies. Consumers are increasingly turning to digital platforms for health consultations, prescription refills, and product purchases. For instance, during the COVID-19 pandemic, Japan experienced a 40% increase in the use of e-prescriptions, reflecting the growing reliance on digital healthcare solutions. Pharmacies are now offering mobile apps, online ordering, home delivery, and digital payment options to meet consumer expectations for convenience and accessibility. E-prescriptions and cloud-based patient data systems enable streamlined order processing and medication tracking, further enhancing operational efficiency. Many pharmacies introduced remote consultations and digital health advice via AI chatbots and licensed professionals, which saw a 25% rise in adoption among urban populations. This trend is particularly appealing to the tech-savvy younger population and busy working professionals who prefer managing their healthcare online. Omnichannel retail also supports data-driven personalization, allowing pharmacies to offer targeted promotions, loyalty programs, and medication reminders. As regulatory frameworks adapt to support digital pharmacy services, Japan’s retail pharmacies are set to become more connected, responsive, and consumer-centric. This ongoing digitization is not only reshaping customer engagement but also reinforcing pharmacies’ roles as critical access points for holistic health management.
Expansion of Health Support and Community-Based Pharmacy Services
A notable trend shaping the Japan retail pharmacy market is the expansion of health support pharmacies and community-based services. For instance, as of 2024, over 12,000 pharmacies in Japan have been certified as “Health Support Pharmacies” (HSPs), offering proactive health consultations, disease prevention education, and nutritional guidance. These pharmacies are positioned as community health hubs that collaborate closely with local clinics and hospitals to deliver continuous patient care. In addition, the focus on “family pharmacies” or “pharmacies of choice” has gained momentum, with surveys indicating that 65% of elderly patients prefer these pharmacies for their personalized support and comprehensive medication management. Pharmacists are receiving expanded training to deliver services like smoking cessation programs, medication therapy management, and vaccinations, with over 80% of pharmacists now certified to administer vaccines. This trend reflects a broader redefinition of the pharmacist’s role from a dispenser to a healthcare provider. It also aligns with Japan’s demographic profile, where a significant portion of the population requires regular health guidance, particularly the elderly. With supportive policy frameworks and growing public trust, community-oriented pharmacy services are strengthening the sector’s relevance in Japan’s evolving healthcare landscape.
Increased Demand for Personalized and Preventive Healthcare Solutions
Japan’s retail pharmacy sector is witnessing a growing demand for personalized and preventive healthcare offerings. As consumers become more health-conscious and proactive in managing their well-being, pharmacies are diversifying their product ranges and services to meet individualized needs. Pharmacies now stock a broader selection of functional foods, nutraceuticals, and supplements tailored to support specific health goals such as immune support, cardiovascular health, and stress reduction. Pharmacogenetic testing and personalized health screening kits are also gaining popularity, allowing individuals to make informed decisions based on their genetic predispositions or biometric markers. Retail pharmacies are increasingly adopting data analytics tools to recommend products or interventions based on customer purchase history, lifestyle, or health conditions. Moreover, wearable technology integration—such as smart thermometers or blood pressure monitors—is enabling consumers to track health metrics and consult pharmacists for actionable insights. This trend aligns with Japan’s cultural emphasis on preventive care and longevity. Pharmacies are actively positioning themselves as trusted wellness partners by offering coaching, diet advice, and long-term health planning. As the healthcare industry continues to shift toward value-based models, personalized services in retail pharmacy settings are emerging as a competitive differentiator and a strategic focus for growth and consumer engagement.
Pharmacy Automation and AI-Driven Efficiency Enhancements
Technological advancements, particularly in automation and artificial intelligence (AI), are significantly influencing the operational models of retail pharmacies in Japan. Automation has become instrumental in reducing dispensing errors, streamlining inventory management, and improving overall workflow. Pharmacies are implementing robotic dispensers, automated pill packaging machines, and smart storage systems to increase throughput and reduce waiting times. These innovations not only improve accuracy but also free up pharmacists to focus on more value-added services such as consultations and health screenings. Simultaneously, AI-powered platforms are being used to forecast demand, personalize promotions, and support decision-making in medication management. Chatbots and virtual assistants are being deployed to handle routine queries, book appointments, and remind patients about prescription refills. With the rise of big data analytics, retail chains are leveraging customer insights to optimize product assortments and operational strategies. Furthermore, pharmacy chains are integrating these technologies with electronic health records (EHRs) to support a more coordinated and intelligent approach to patient care. This digital transformation is driven by Japan’s emphasis on innovation, efficiency, and patient safety. As automation and AI adoption expand, pharmacies are evolving from transactional retail points into highly efficient, tech-enabled healthcare access hubs, ensuring scalability and improved service quality in a competitive market landscape.
Market Challenges
Workforce Shortages and Strain on Pharmacist Resources
One of the major challenges confronting the Japan retail pharmacy market is the shortage of qualified pharmacists and healthcare personnel. Despite increasing demand for pharmaceutical services due to an aging population and the rising incidence of chronic diseases, the supply of pharmacists has not kept pace. This shortage creates a significant burden on existing pharmacy staff, leading to increased workloads, longer waiting times for customers, and reduced opportunities for pharmacists to offer value-added services such as patient counseling and medication therapy management. Smaller, independent pharmacies, in particular, face difficulties in attracting and retaining qualified pharmacists. For instance, nearly 40% of independent pharmacies in Japan report challenges in hiring pharmacists, resulting in operational inefficiencies and reduced competitiveness compared to large pharmacy chains. Furthermore, the growing complexity of pharmaceutical care—such as the need for medication reconciliation, adverse drug reaction monitoring, and chronic disease management—places additional pressure on pharmacists to expand their roles. Without sufficient staffing levels, pharmacies struggle to maintain high standards of service quality, customer satisfaction, and compliance with regulatory expectations. Addressing this workforce challenge requires strategic efforts, including promoting pharmacy education, improving working conditions, leveraging pharmacy automation technologies, and fostering professional development programs to equip pharmacists for evolving healthcare roles.
Regulatory Constraints and Intensifying Price Pressures
Japan’s retail pharmacy market also grapples with stringent regulatory frameworks and increasing price pressures that challenge profitability and business sustainability. Government-mandated drug price revisions, which occur regularly to control healthcare spending, result in declining reimbursement rates for prescription medications. These revisions negatively impact pharmacy revenues, particularly for pharmacies heavily reliant on prescription sales. In addition, regulatory requirements for accreditation as Health Support Pharmacies impose operational burdens, as they demand additional investments in staff training, facility upgrades, and service expansion. Compliance with these regulations can be financially taxing, especially for small and mid-sized pharmacy operators. Simultaneously, intense market competition among pharmacy chains, drugstores, and online pharmacies has triggered aggressive price wars, further squeezing profit margins. Consumers’ growing price sensitivity, driven by widespread availability of generic drugs and discounted OTC products, exacerbates this issue. To navigate these challenges, retail pharmacies must diversify revenue streams by offering healthcare services, digital solutions, and wellness products. Strategic adaptation, operational efficiency improvements, and collaboration with broader healthcare networks are critical to sustaining profitability and maintaining relevance in Japan’s evolving pharmaceutical landscape.
Market Opportunities
Expansion of Integrated Healthcare Services through Pharmacies
The Japan retail pharmacy market holds strong opportunities for growth through the expansion of integrated healthcare services. As the healthcare system increasingly shifts toward preventive care and community-based models, pharmacies are well-positioned to offer broader services beyond traditional medication dispensing. Health support pharmacies (HSPs) present a significant opportunity for retailers to become essential healthcare hubs by providing nutritional counseling, chronic disease management, health screenings, vaccination services, and medication adherence programs. Collaborations between pharmacies, local clinics, and public health agencies can create comprehensive care networks that address the needs of an aging population while reducing strain on hospitals. Pharmacies that proactively integrate primary care services and leverage patient education initiatives can differentiate themselves competitively, build customer loyalty, and secure new revenue streams supported by evolving government policies promoting decentralized healthcare access.
Leveraging Digital Health and E-Commerce Expansion
Another major market opportunity lies in the strategic adoption of digital health technologies and e-commerce platforms. The rapid consumer shift toward online health management and telepharmacy services creates a favorable environment for pharmacies to expand their reach digitally. Offering services such as e-prescriptions, online medication ordering, virtual consultations, and home delivery can significantly enhance customer engagement and convenience. Additionally, data-driven insights from digital interactions enable pharmacies to personalize services, recommend targeted health solutions, and optimize inventory management. Pharmacies that invest in robust digital infrastructure and omnichannel strategies will be better positioned to meet the needs of tech-savvy consumers, strengthen brand loyalty, and capture a larger share of the evolving healthcare retail market in Japan.
Market Segmentation Analysis
By Type of Pharmacy
The Japan retail pharmacy market is segmented into chain pharmacies, independent pharmacies, hospital pharmacies, mail order pharmacies, and online pharmacies. Chain pharmacies dominate the market due to their extensive geographic reach, brand recognition, and diversified service offerings. These pharmacies benefit from economies of scale and strong partnerships with pharmaceutical manufacturers. Independent pharmacies, although smaller in scale, retain significance in rural and suburban areas by offering personalized services. Hospital pharmacies primarily serve in-house patients but are expanding their outpatient operations to provide more accessible pharmaceutical care. Mail order pharmacies are gaining traction among patients with chronic conditions requiring regular medication refills, supported by home delivery services. Meanwhile, online pharmacies are experiencing rapid growth, fueled by the increasing demand for digital convenience and regulatory support for e-prescriptions.
By Type of Prescription
The market is bifurcated into prescription drugs (Rx) and over-the-counter (OTC) drugs. Prescription drugs contribute the majority of revenue, driven by the high prevalence of chronic diseases and the aging population’s medication needs. However, the OTC segment is expanding as consumers increasingly seek self-care solutions for minor health issues, boosting the sales of non-prescription medications, supplements, and preventive products.
Segments
Based on Type of Pharmacy
Chain Pharmacies
Independent Pharmacies
Hospital Pharmacies
Mail Order Pharmacies
Online Pharmacies
Based on Type of prescription
Prescription Drugs (Rx)
Over-the-Counter (OTC) Drugs
Based on Service offered
Medication Dispensing
Health Screenings
Vaccination Services
Consultation and Counseling
Chronic Disease Management
Based on Product Type
Generic Drugs
Branded Drugs
Based on Application
Oncology
Diabetes
Neurology
Others
Based on Customer
Paediatric
Adults
Geriatric
Based on Region
Kanto
Kansai
Chubu
Regional Analysis
Kanto region (45-50%)
The Kanto region, encompassing the Greater Tokyo Area, commands the largest market share at approximately 45–50%. This dominance is attributed to its high population density, advanced healthcare facilities, and the presence of numerous hospitals and pharmacies. The region’s adoption of cutting-edge technologies and pharmacy automation further bolsters its market position.
Kansai region (20-25%)
The Kansai region, including major cities like Osaka and Kyoto, holds a substantial market share of around 20–25%. Known for its well-developed healthcare sector, Kansai benefits from a high concentration of medical institutions and a focus on improving healthcare efficiency and patient safety. The region’s commitment to enhancing healthcare services has driven the adoption of pharmacy automation solutions.
Chubu region (10-15%)
The Chubu region, with cities such as Nagoya, accounts for approximately 10–15% of the market. Its strategic location and robust industrial base contribute to a growing demand for healthcare services, including retail pharmacies. The region’s emphasis on integrating technology into healthcare practices supports the expansion of pharmacy services.
Key players
Matsumoto Kiyoshi Holdings Co., Ltd
Aeon Co., Ltd
Lawson, Inc
Tsuruha Holdings Inc
FamilyMart Co., Ltd
Competitive Analysis
The Japan retail pharmacy market is highly competitive, characterized by the strong presence of both established pharmacy chains and diversified retail groups. Leading players such as Matsumoto Kiyoshi Holdings Co., Ltd and Tsuruha Holdings Inc dominate the landscape with extensive store networks, strong brand recognition, and broad product portfolios, spanning prescription drugs, OTC products, and wellness goods. Aeon Co., Ltd and FamilyMart Co., Ltd leverage their diversified retail operations to integrate pharmacy services into their broader consumer offerings, enhancing customer convenience. Lawson, Inc has also strategically expanded its healthcare segment through partnerships and in-store pharmacies. Competition is intensifying as players invest in digitalization, expand health-related services, and adopt customer-centric business models to strengthen market share. The focus on preventive healthcare, personalized services, and omnichannel engagement is reshaping competitive dynamics, compelling companies to innovate continuously to maintain their leadership in Japan’s evolving retail pharmacy market.
Recent Developments
As of March 31, 2024, Apollo Pharmacy operated 6,030 stores across approximately 1,200 cities and towns in 22 states and 5 union territories. The company continues to expand its digital healthcare platform, offering services like online medicine delivery and virtual doctor consultations.
In October 2024, Caring Pharmacy Retail Management Sdn Bhd, a 75%-owned unit of 7-Eleven Malaysia Holdings Bhd, announced acquisitions of equity interest and business assets in several pharmaceutical outlets for a combined cash consideration of RM48.86 million.
In June 2024, the Australian Competition and Consumer Commission (ACCC) expressed concerns that the proposed acquisition of Chemist Warehouse by Sigma Healthcare could substantially lessen competition in pharmacy retailing, potentially leading to higher prices and reduced service quality.
In January 2025, Watsons Philippines ended 2024 with 1,166 stores, expanding its community pharmacy format. The company opened more than 50 stores outside of Metro Manila.
Market Concentration and Characteristics
The Japan retail pharmacy market exhibits a moderately concentrated structure, with a few dominant players such as Matsumoto Kiyoshi Holdings Co., Ltd, Tsuruha Holdings Inc, Aeon Co., Ltd, and FamilyMart Co., Ltd commanding significant market shares. These companies benefit from extensive retail networks, strong brand equity, and diversified service offerings that include prescription dispensing, OTC sales, and preventive healthcare services. The market is characterized by a blend of traditional brick-and-mortar outlets and rapidly growing online pharmacy platforms, driven by the increasing consumer preference for convenience and digital health solutions. Regulatory initiatives supporting Health Support Pharmacies and the promotion of generic drugs are shaping operational strategies across the sector. Moreover, the market reflects a strong emphasis on personalized healthcare, community-based services, and the integration of pharmacy automation technologies to enhance service efficiency. Competitive intensity remains high, encouraging continuous innovation, strategic partnerships, and regional expansion to cater to Japan’s aging and health-conscious population.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The research report offers an in-depth analysis based on Type of Pharmacy, Type of prescription, Service offered, Product Type, Application, Customer and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The Japan retail pharmacy market will continue to grow steadily, driven by the expanding elderly population and increasing chronic disease burden across the country.
Pharmacies will strengthen their roles as primary healthcare hubs by offering expanded services such as health screenings, chronic disease management, and vaccination programs.
The adoption of digital health platforms, including e-prescriptions, telepharmacy services, and mobile health applications, will enhance consumer convenience and loyalty.
Online pharmacies and mail-order services will experience strong growth, supported by regulatory advancements and the increasing demand for contactless healthcare options.
Health Support Pharmacies will become more widespread, as government initiatives encourage pharmacies to offer community-based health promotion and preventive care services.
Pharmacy chains will invest heavily in automation technologies, such as robotic dispensing and AI-driven inventory management, to improve operational efficiency and reduce errors.
The growing popularity of self-medication and preventive healthcare will boost the sales of OTC drugs, health supplements, and functional foods in retail pharmacies.
Strategic collaborations between pharmacies, hospitals, and technology companies will emerge to deliver integrated, patient-centric healthcare solutions across Japan.
The market will witness increased competition, prompting players to focus on personalized service offerings, loyalty programs, and regional expansions to secure market share.
Sustainability initiatives, including eco-friendly packaging and carbon footprint reduction efforts, will gain prominence as pharmacies align with broader environmental and social governance trends.
CHAPTER NO. 1 : INTRODUCTION 19
1.1.1. Report Description 19 Purpose of the Report 19 USP & Key Offerings 19
1.1.2. Key Benefits for Stakeholders 19
1.1.3. Target Audience 20
1.1.4. Report Scope 20 CHAPTER NO. 2 : EXECUTIVE SUMMARY 21
2.1. Japan Retail Pharmacy Market Snapshot 21
2.1.1. Japan Retail Pharmacy Market, 2018 – 2032 (USD Million) 22 CHAPTER NO. 3 : JAPAN RETAIL PHARMACY MARKET – INDUSTRY ANALYSIS 23
3.1. Introduction 23
3.2. Market Drivers 24
3.2.1. Increasing Prevalence of Chronic Conditions 24
3.2.2. Aging Population 25
3.3. Market Restraints 26
3.3.1. Reimbursement and Payment Issues 26
3.4. Market Opportunities 27
3.4.1. Market Opportunity Analysis 27
3.5. Porter’s Five Forces Analysis 28 CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 29
4.1. Company Market Share Analysis – 2024 29
4.1.1. Japan Retail Pharmacy Market: Company Market Share, by Volume, 2024 29
4.1.2. Japan Retail Pharmacy Market: Company Market Share, by Revenue, 2024 30
4.1.3. Japan Retail Pharmacy Market: Top 6 Company Market Share, by Revenue, 2024 30
4.1.4. Japan Retail Pharmacy Market: Top 3 Company Market Share, by Revenue, 2024 31
4.2. Japan Retail Pharmacy Market Company Revenue Market Share, 2024 32
4.3. Company Assessment Metrics, 2024 33
4.3.1. Stars 33
4.3.2. Emerging Leaders 33
4.3.3. Pervasive Players 33
4.3.4. Participants 33
4.4. Start-ups /SMEs Assessment Metrics, 2024 33
4.4.1. Progressive Companies 33
4.4.2. Responsive Companies 33
4.4.3. Dynamic Companies 33
4.4.4. Starting Blocks 33
4.5. Strategic Developments 34
4.5.1. Acquisitions & Mergers 34 New Product Launch 34 Regional Expansion 34
4.6. Key Players Product Matrix 35 CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 36
5.1. PESTEL 36
5.1.1. Political Factors 36
5.1.2. Economic Factors 36
5.1.3. Social Factors 36
5.1.4. Technological Factors 36
5.1.5. Environmental Factors 36
5.1.6. Legal Factors 36
5.2. Adjacent Market Analysis 36 CHAPTER NO. 6 : JAPAN RETAIL PHARMACY MARKET – BY TYPE OF PHARMACY SEGMENT ANALYSIS 37
6.1. Japan Retail Pharmacy Market Overview, by Type of Pharmacy Segment 37
6.1.1. Japan Retail Pharmacy Market Revenue Share, By Type of Pharmacy, 2023 & 2032 38
6.1.2. Japan Retail Pharmacy Market Attractiveness Analysis, By Type of Pharmacy 39
6.1.3. Incremental Revenue Growth Opportunity, by Type of Pharmacy, 2024 – 2032 39
6.1.4. Japan Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018, 2023, 2027 & 2032 40
6.2. Chain Pharmacies 41
6.3. Independent Pharmacies 42
6.4. Hospital Pharmacies 43
6.5. Mail Order Pharmacies 44
6.6. Online Pharmacies 45 CHAPTER NO. 7 : JAPAN RETAIL PHARMACY MARKET – BY TYPE OF PRESCRIPTION SEGMENT ANALYSIS 46
7.1. Japan Retail Pharmacy Market Overview, by Type of Prescription Segment 46
7.1.1. Japan Retail Pharmacy Market Revenue Share, By Type of Prescription, 2023 & 2032 47
7.1.2. Japan Retail Pharmacy Market Attractiveness Analysis, By Type of Prescription 48
7.1.3. Incremental Revenue Growth Opportunity, by Type of Prescription, 2024 – 2032 48
7.1.4. Japan Retail Pharmacy Market Revenue, By Type of Prescription, 2018, 2023, 2027 & 2032 49
7.2. Prescription Drugs (Rx) 50
7.3. Over-the-Counter (OTC) Drugs 51 CHAPTER NO. 8 : JAPAN RETAIL PHARMACY MARKET – BY SERVICE OFFERED SEGMENT ANALYSIS 52
8.1. Japan Retail Pharmacy Market Overview, by Service Offered Segment 52
8.1.1. Japan Retail Pharmacy Market Revenue Share, By Service Offered, 2023 & 2032 53
8.1.2. Japan Retail Pharmacy Market Attractiveness Analysis, By Service Offered 54
8.1.3. Incremental Revenue Growth Opportunity, by Service Offered, 2024 – 2032 54
8.1.4. Japan Retail Pharmacy Market Revenue, By Service Offered, 2018, 2023, 2027 & 2032 55
8.2. Medication Dispensing 56
8.3. Health Screenings 57
8.4. Vaccination Services 58
8.5. Consultation and Counseling 59
8.6. Chronic Disease Management 60 CHAPTER NO. 9 : JAPAN RETAIL PHARMACY MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS 61
9.1. Japan Retail Pharmacy Market Overview, by Product Type Segment 61
9.1.1. Japan Retail Pharmacy Market Revenue Share, By Product Type, 2023 & 2032 62
9.1.2. Japan Retail Pharmacy Market Attractiveness Analysis, By Product Type 63
9.1.3. Incremental Revenue Growth Opportunity, by Product Type, 2024 – 2032 63
9.1.4. Japan Retail Pharmacy Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 64
9.2. Generic Drugs 65
9.3. Branded Drugs 66 CHAPTER NO. 10 : JAPAN RETAIL PHARMACY MARKET – BY APPLICATION SEGMENT ANALYSIS 67
10.1. Japan Retail Pharmacy Market Overview, by Application Segment 67
10.1.1. Japan Retail Pharmacy Market Revenue Share, By Application , 2023 & 2032 68
10.1.2. Japan Retail Pharmacy Market Attractiveness Analysis, By Application 69
10.1.3. Incremental Revenue Growth Opportunity, by Application , 2024 – 2032 69
10.1.4. Japan Retail Pharmacy Market Revenue, By Application , 2018, 2023, 2027 & 2032 70
10.2. Oncology 71
10.3. Diabetes 72
10.4. Neurology 73
10.5. Others 74 CHAPTER NO. 11 : JAPAN RETAIL PHARMACY MARKET – BY CUSTOMER SEGMENT ANALYSIS 75
11.1. Japan Retail Pharmacy Market Overview, by Customer Segment 75
11.1.1. Japan Retail Pharmacy Market Revenue Share, By Customer Segment, 2023 & 2032 76
11.1.2. Japan Retail Pharmacy Market Attractiveness Analysis, By Customer Segment 77
11.1.3. Incremental Revenue Growth Opportunity, by Customer Segment, 2024 – 2032 77
11.1.4. Japan Retail Pharmacy Market Revenue, By Customer Segment, 2018, 2023, 2027 & 2032 78
11.2. Paediatric 79
11.3. Adults 80
11.4. Geriatric 80 CHAPTER NO. 12 : JAPAN RETAIL PHARMACY MARKET – ANALYSIS 81
12.1. Type of Pharmacy 81
12.1.1. Japan Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018 – 2023 (USD Million) 81
12.1.2. Japan Retail Pharmacy Market Revenue, By Type of Pharmacy, 2024 – 2032 (USD Million) 81
12.2. Type of Prescription 82
12.2.1. Japan Retail Pharmacy Market Revenue, By Type of Prescription, 2018 – 2023 (USD Million) 82
12.2.2. Japan Retail Pharmacy Market Revenue, By Type of Prescription, 2024 – 2032 (USD Million) 82
12.3. Service Offered 83
12.3.1. Japan Retail Pharmacy Market Revenue, By Service Offered, 2018 – 2023 (USD Million) 83
12.3.2. Japan Retail Pharmacy Market Revenue, By Service Offered, 2024 – 2032 (USD Million) 83
12.4. Product Type 84
12.4.1. Japan Retail Pharmacy Market Revenue, By Product Type, 2018 – 2023 (USD Million) 84
12.4.2. Japan Retail Pharmacy Market Revenue, By Product Type, 2024 – 2032 (USD Million) 84
12.5. Application 85
12.5.1. Japan Retail Pharmacy Market Revenue, By Application, 2018 – 2023 (USD Million) 85
12.5.2. Japan Retail Pharmacy Market Revenue, By Application, 2024 – 2032 (USD Million) 85
12.6. Customer Segment 86
12.6.1. Japan Retail Pharmacy Market Revenue, By Customer Segment, 2018 – 2023 (USD Million) 86
12.6.2. Japan Retail Pharmacy Market Revenue, By Customer Segment, 2024 – 2032 (USD Million) 86 CHAPTER NO. 13 : COMPANY PROFILES 87
13.1. Matsumoto Kiyoshi Holdings Co., Ltd 87
13.1.1. Company Overview 87
13.1.2. Product Portfolio 87
13.1.3. Swot Analysis 87
13.1.4. Business Strategy 88
13.1.5. Financial Overview 88
13.2. Aeon Co., Ltd 89
13.3. Lawson, Inc 89
13.4. Tsuruha Holdings Inc 89
13.5. FamilyMart Co., Ltd 89
13.6. Company 6 89
13.7. Company 7 89
13.8. Company 8 89
13.9. Company 9 89
13.10. Company 10 89
List of Figures
FIG NO. 1. Japan Retail Pharmacy Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Japan Retail Pharmacy Market 28
FIG NO. 3. Company Share Analysis, 2024 29
FIG NO. 4. Company Share Analysis, 2024 30
FIG NO. 5. Company Share Analysis, 2024 30
FIG NO. 6. Company Share Analysis, 2024 31
FIG NO. 7. Japan Retail Pharmacy Market – Company Revenue Market Share, 2024 32
FIG NO. 8. Japan Retail Pharmacy Market Revenue Share, By Type of Pharmacy, 2023 & 2032 38
FIG NO. 9. Market Attractiveness Analysis, By Type of Pharmacy 39
FIG NO. 10. Incremental Revenue Growth Opportunity by Type of Pharmacy, 2024 – 2032 39
FIG NO. 11. Japan Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018, 2023, 2027 & 2032 40
FIG NO. 12. Japan Retail Pharmacy Market for Chain Pharmacies, Revenue (USD Million) 2018 – 2032 41
FIG NO. 13. Japan Retail Pharmacy Market for Independent Pharmacies, Revenue (USD Million) 2018 – 2032 42
FIG NO. 14. Japan Retail Pharmacy Market for Hospital Pharmacies, Revenue (USD Million) 2018 – 2032 43
FIG NO. 15. Japan Retail Pharmacy Market for Mail Order Pharmacies, Revenue (USD Million) 2018 – 2032 44
FIG NO. 16. Japan Retail Pharmacy Market for Online Pharmacies, Revenue (USD Million) 2018 – 2032 45
FIG NO. 17. Japan Retail Pharmacy Market Revenue Share, By Type of Prescription, 2023 & 2032 47
FIG NO. 18. Market Attractiveness Analysis, By Type of Prescription 48
FIG NO. 19. Incremental Revenue Growth Opportunity by Type of Prescription, 2024 – 2032 48
FIG NO. 20. Japan Retail Pharmacy Market Revenue, By Type of Prescription, 2018, 2023, 2027 & 2032 49
FIG NO. 21. Japan Retail Pharmacy Market for Prescription Drugs (Rx), Revenue (USD Million) 2018 – 2032 50
FIG NO. 22. Japan Retail Pharmacy Market for Over-the-Counter (OTC) Drugs, Revenue (USD Million) 2018 – 2032 51
FIG NO. 23. Japan Retail Pharmacy Market Revenue Share, By Service Offered, 2023 & 2032 53
FIG NO. 24. Market Attractiveness Analysis, By Service Offered 54
FIG NO. 25. Incremental Revenue Growth Opportunity by Service Offered, 2024 – 2032 54
FIG NO. 26. Japan Retail Pharmacy Market Revenue, By Service Offered, 2018, 2023, 2027 & 2032 55
FIG NO. 27. Japan Retail Pharmacy Market for Medication Dispensing, Revenue (USD Million) 2018 – 2032 56
FIG NO. 28. Japan Retail Pharmacy Market for Health Screenings, Revenue (USD Million) 2018 – 2032 57
FIG NO. 29. Japan Retail Pharmacy Market for Vaccination Services, Revenue (USD Million) 2018 – 2032 58
FIG NO. 30. Japan Retail Pharmacy Market for Consultation and Counseling, Revenue (USD Million) 2018 – 2032 59
FIG NO. 31. Japan Retail Pharmacy Market for Chronic Disease Management, Revenue (USD Million) 2018 – 2032 60
FIG NO. 32. Japan Retail Pharmacy Market Revenue Share, By Product Type, 2023 & 2032 62
FIG NO. 33. Market Attractiveness Analysis, By Product Type 63
FIG NO. 34. Incremental Revenue Growth Opportunity by Product Type, 2024 – 2032 63
FIG NO. 35. Japan Retail Pharmacy Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 64
FIG NO. 36. Japan Retail Pharmacy Market for Generic Drugs, Revenue (USD Million) 2018 – 2032 65
FIG NO. 37. Japan Retail Pharmacy Market for Branded Drugs, Revenue (USD Million) 2018 – 2032 66
FIG NO. 38. Japan Retail Pharmacy Market Revenue Share, By Application , 2023 & 2032 68
FIG NO. 39. Market Attractiveness Analysis, By Application 69
FIG NO. 40. Incremental Revenue Growth Opportunity by Application , 2024 – 2032 69
FIG NO. 41. Japan Retail Pharmacy Market Revenue, By Application , 2018, 2023, 2027 & 2032 70
FIG NO. 42. Japan Retail Pharmacy Market for Oncology, Revenue (USD Million) 2018 – 2032 71
FIG NO. 43. Japan Retail Pharmacy Market for Diabetes, Revenue (USD Million) 2018 – 2032 72
FIG NO. 44. Japan Retail Pharmacy Market for Neurology, Revenue (USD Million) 2018 – 2032 73
FIG NO. 45. Japan Retail Pharmacy Market for Others, Revenue (USD Million) 2018 – 2032 74
FIG NO. 46. Japan Retail Pharmacy Market Revenue Share, By Customer Segment, 2023 & 2032 76
FIG NO. 47. Market Attractiveness Analysis, By Customer Segment 77
FIG NO. 48. Incremental Revenue Growth Opportunity by Customer Segment, 2024 – 2032 77
FIG NO. 49. Japan Retail Pharmacy Market Revenue, By Customer Segment, 2018, 2023, 2027 & 2032 78
FIG NO. 50. Japan Retail Pharmacy Market for Pediatric, Revenue (USD Million) 2018 – 2032 79
FIG NO. 51. Japan Retail Pharmacy Market for Adults, Revenue (USD Million) 2018 – 2032 80
FIG NO. 52. Japan Retail Pharmacy Market for Geriatric, Revenue (USD Million) 2018 – 2032 80
List of Tables
TABLE NO. 1. : Japan Retail Pharmacy Market: Snapshot 21
TABLE NO. 2. : Drivers for the Japan Retail Pharmacy Market: Impact Analysis 24
TABLE NO. 3. : Restraints for the Japan Retail Pharmacy Market: Impact Analysis 26
TABLE NO. 4. : Japan Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018 – 2023 (USD Million) 81
TABLE NO. 5. : Japan Retail Pharmacy Market Revenue, By Type of Pharmacy, 2024 – 2032 (USD Million) 81
TABLE NO. 6. : Japan Retail Pharmacy Market Revenue, By Type of Prescription, 2018 – 2023 (USD Million) 82
TABLE NO. 7. : Japan Retail Pharmacy Market Revenue, By Type of Prescription, 2024 – 2032 (USD Million) 82
TABLE NO. 8. : Japan Retail Pharmacy Market Revenue, By Service Offered, 2018 – 2023 (USD Million) 83
TABLE NO. 9. : Japan Retail Pharmacy Market Revenue, By Service Offered, 2024 – 2032 (USD Million) 83
TABLE NO. 10. : Japan Retail Pharmacy Market Revenue, By Product Type, 2018 – 2023 (USD Million) 84
TABLE NO. 11. : Japan Retail Pharmacy Market Revenue, By Product Type, 2024 – 2032 (USD Million) 84
TABLE NO. 12. : Japan Retail Pharmacy Market Revenue, By Application, 2018 – 2023 (USD Million) 85
TABLE NO. 13. : Japan Retail Pharmacy Market Revenue, By Application, 2024 – 2032 (USD Million) 85
TABLE NO. 14. : Japan Retail Pharmacy Market Revenue, By Customer Segment, 2018 – 2023 (USD Million) 86
TABLE NO. 15. : Japan Retail Pharmacy Market Revenue, By Customer Segment, 2024 – 2032 (USD Million) 86
Frequently Asked Questions:
What is the market size of the Japan Retail Pharmacy Market in 2023 and 2032?
The Japan Retail Pharmacy Market is projected to reach USD 52,569.90 million in 2024 and grow to USD 73,311.06 million by 2032, with a compound annual growth rate (CAGR) of 4.24% from 2025 to 2032.
What are the key drivers of growth in the Japan Retail Pharmacy Market?
The market’s growth is driven by an aging population, increased chronic disease prevalence, and the expansion of retail pharmacy chains, along with technological advancements in pharmacy automation and digital services.
Which region holds the largest share in the Japan Retail Pharmacy Market?
The Kanto region, including Tokyo, holds the largest market share due to its dense population and high healthcare demand, driving the growth of retail pharmacies in the area.
What are the major segments in the Japan Retail Pharmacy Market?
The key segments of the market include prescription medications, over-the-counter (OTC) products, and health and wellness items, with prescription medications holding the largest revenue share.
Who are the leading players in the Japan Retail Pharmacy Market?
Major players in the Japan Retail Pharmacy Market include Tsuruha Holdings, Welcia Holdings, and Matsumoto Kiyoshi Holdings, all of which dominate the market with extensive store networks and a broad range of products.
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.
